Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 01 1996, 79-83, Vol 3, No. 1
JB Black, TF Schwarz, JL Patton, K Kite-Powell, PE Pellett, S Wiersbitzky, R Bruns, C Muller, G Jager and JA Stewart
An enzyme immunoassay (EIA), an immunoblot assay (IB), and an indirect
immunofluorescence assay were developed for detection of human herpesvirus
7 (HHV-7) antibodies in human serum. Cross-absorption studies with EIA or
IFA using HHV-7 and human herpesvirus 6 (HHV-6) antigens indicated that
most human sera contain cross-reactive HHV-6 and HHV-7 antibodies and that
the degree of cross-reactivity varies between individual serum specimens.
Inhibition of homologous antibody activity by absorption with heterologous
virus ranged from 0 to 57% by EIA. However, for every sample tested,
absorption with homologous virus removed more activity than did
heterologous virus. An 89-kDa protein was identified as an HHV-7-specific
serologic marker by IB. Activity to this protein was not removed by
absorption with HHV-6 antigen. Of the three assays, the EIA was the most
sensitive (94%), while the IB was the most specific (94%). Approximately
80% of specimens collected from German adults and children older than 2
years were positive for HHV-7 antibodies by these assays.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Evaluation of immunoassays for detection of antibodies to human herpesvirus 7
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. JXB1@ciddvd1.em.cclc.gov
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |